The Procter & Gamble Company (PG) 10-Year Financial Performance & Capital Metrics

PG • • Industrial / General

Consumer DefensiveHousehold ProductsPersonal Care & CosmeticsSkincare & Hair Care

AboutThe Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.Show more

Revenue $84.28B +0.3%
EBITDA $23.3B +8.7%
Net Income $15.97B +7.4%
EPS (Diluted) 6.51 +8.1%
Gross Margin 51.16% -0.5%
EBITDA Margin 27.64% +8.3%
Operating Margin 24.26% +10.0%
Net Margin 18.95% +7.0%
ROE 31.07% +1.9%
ROIC 20.1% +7.4%
Debt/Equity 0.68 +2.8%
Interest Coverage 22.55 +12.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Dividend Aristocrat: 36 years of consecutive increases
✓Excellent 3Y average ROE of 30.9%
✓FCF machine: 16.7% free cash flow margin
✓Healthy dividend yield of 2.8%
✓Healthy 5Y average net margin of 18.3%

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y1.77%

5Y3.5%

3Y1.67%

TTM1.23%

Profit (Net Income) CAGR

10Y8.54%

5Y4.16%

3Y2.71%

TTM17.09%

EPS CAGR

10Y10.31%

5Y5.59%

3Y3.86%

TTM18.72%

ROCE

10Y Avg17.51%

5Y Avg21.47%

3Y Avg21.92%

Latest22.99%

Peer Comparison

Skincare & Hair Care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AXILAXIL Brands, Inc.	52.99M	7.79	77.90	-4.51%	3.26%	8.85%	2.9%	0.08
ULUnilever PLC	141.09B	64.70	28.25	1.94%	10.16%	61.19%	5.51%	1.36
CLColgate-Palmolive Company	66.87B	82.96	23.64	3.31%	14.47%	234.81%	5.3%	15.65
PGThe Procter & Gamble Company	337.05B	144.24	22.16	0.29%	19.74%	31.31%	4.17%	0.68
SLSNSolesence, Inc. Common Stock	107.22M	1.52	21.71	40.35%	1.72%	6.21%		1.02
EPCEdgewell Personal Care Company	861.43M	18.44	9.36	0.09%	2.94%	4.13%	20.26%	0.87
UGUnited-Guardian, Inc.	28.76M	6.26	8.82	11.91%	19.48%	18.52%	10.55%

Profit & Loss

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Sales/Revenue+	65.3B	65.06B	66.83B	67.68B	70.95B	76.12B	80.19B	82.01B	84.04B	84.28B
Revenue Growth %	-0.08%	-0%	0.03%	0.01%	0.05%	0.07%	0.05%	0.02%	0.02%	0%
Cost of Goods Sold+	32.91B	32.64B	34.43B	34.77B	35.25B	37.11B	42.16B	42.76B	40.85B	41.16B
COGS % of Revenue	0.5%	0.5%	0.52%	0.51%	0.5%	0.49%	0.53%	0.52%	0.49%	0.49%
Gross Profit+	32.39B	32.42B	32.4B	32.92B	35.7B	39.01B	38.03B	39.25B	43.19B	43.12B
Gross Margin %	0.5%	0.5%	0.48%	0.49%	0.5%	0.51%	0.47%	0.48%	0.51%	0.51%
Gross Profit Growth %	-0.04%	0%	-0%	0.02%	0.08%	0.09%	-0.03%	0.03%	0.1%	-0%
Operating Expenses+	18.95B	18.65B	19.04B	27.43B	19.99B	21.02B	20.22B	21.11B	24.65B	22.67B
OpEx % of Revenue	0.29%	0.29%	0.28%	0.41%	0.28%	0.28%	0.25%	0.26%	0.29%	0.27%
Selling, General & Admin	18.95B	18.65B	18.71B	18.71B	19.99B	21.02B	20.22B	21.11B	23.3B	21.66B
SG&A % of Revenue	0.29%	0.29%	0.28%	0.28%	0.28%	0.28%	0.25%	0.26%	0.28%	0.26%
Research & Development	0	0	0	1.9B	0	0	0	0	0	2.1B
R&D % of Revenue	-	-	-	0.03%	-	-	-	-	-	0.02%
Other Operating Expenses	0	0	0	6.82B	0	0	0	0	1.34B	-1.09B
Operating Income+	13.44B	13.77B	13.36B	5.49B	15.71B	17.99B	17.81B	18.13B	18.55B	20.45B
Operating Margin %	0.21%	0.21%	0.2%	0.08%	0.22%	0.24%	0.22%	0.22%	0.22%	0.24%
Operating Income Growth %	0.22%	0.02%	-0.03%	-0.59%	1.86%	0.15%	-0.01%	0.02%	0.02%	0.1%
EBITDA+	16.52B	16.59B	16.2B	8.31B	18.72B	20.72B	20.62B	20.85B	21.44B	23.3B
EBITDA Margin %	0.25%	0.25%	0.24%	0.12%	0.26%	0.27%	0.26%	0.25%	0.26%	0.28%
EBITDA Growth %	0.16%	0%	-0.02%	-0.49%	1.25%	0.11%	-0%	0.01%	0.03%	0.09%
D&A (Non-Cash Add-back)	3.08B	2.82B	2.83B	2.82B	3.01B	2.73B	2.81B	2.71B	2.9B	2.85B
EBIT	13.95B	13.72B	13.83B	6.58B	16.3B	18.12B	18.43B	19.11B	19.69B	21.07B
Net Interest Income+	-397M	-294M	-259M	-289M	-310M	-457M	-388M	-449M	-452M	-438M
Interest Income	182M	171M	247M	220M	155M	45M	51M	307M	473M	469M
Interest Expense	579M	465M	506M	509M	465M	502M	439M	756M	925M	907M
Other Income/Expense	-72M	-509M	-37M	582M	128M	-371M	182M	219M	216M	-284M
Pretax Income+	13.37B	13.26B	13.33B	6.07B	15.83B	17.61B	18B	18.35B	18.76B	20.17B
Pretax Margin %	0.2%	0.2%	0.2%	0.09%	0.22%	0.23%	0.22%	0.22%	0.22%	0.24%
Income Tax+	3.34B	3.06B	3.46B	2.1B	2.73B	3.26B	3.2B	3.62B	3.79B	4.1B
Effective Tax Rate %	0.79%	1.16%	0.73%	0.64%	0.82%	0.81%	0.82%	0.8%	0.79%	0.79%
Net Income+	10.51B	15.33B	9.75B	3.9B	13.03B	14.31B	14.74B	14.65B	14.88B	15.97B
Net Margin %	0.16%	0.24%	0.15%	0.06%	0.18%	0.19%	0.18%	0.18%	0.18%	0.19%
Net Income Growth %	0.49%	0.46%	-0.36%	-0.6%	2.34%	0.1%	0.03%	-0.01%	0.02%	0.07%
Net Income (Continuing)	10.03B	10.19B	9.86B	3.97B	13.1B	14.35B	14.79B	14.74B	14.97B	16.07B
Discontinued Operations	577M	5.22B	0	0	0	0	0	0	0	0
Minority Interest	642M	594M	590M	385M	357M	276M	265M	288M	272M	272M
EPS (Diluted)+	3.69	5.59	3.67	1.43	4.96	5.50	5.81	5.90	6.02	6.51
EPS Growth %	0.51%	0.51%	-0.34%	-0.61%	2.47%	0.11%	0.06%	0.02%	0.02%	0.08%
EPS (Basic)	3.80	5.80	3.75	1.45	5.13	5.69	6.00	6.07	6.18	6.67
Diluted Shares Outstanding	2.84B	2.74B	2.66B	2.54B	2.63B	2.6B	2.54B	2.48B	2.47B	2.45B
Basic Shares Outstanding	2.77B	2.6B	2.53B	2.5B	2.54B	2.51B	2.46B	2.37B	2.36B	2.45B
Dividend Payout Ratio	0.71%	0.47%	0.75%	1.92%	0.6%	0.58%	0.59%	0.61%	0.63%	0.62%

Balance Sheet

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Current Assets+	33.78B	26.49B	23.32B	22.47B	27.99B	23.09B	21.65B	22.65B	24.71B	25.39B
Cash & Short-Term Investments	13.35B	15.14B	11.85B	10.29B	16.18B	10.29B	7.21B	8.25B	9.48B	9.56B
Cash Only	7.1B	5.57B	2.57B	4.24B	16.18B	10.29B	7.21B	8.25B	9.48B	9.56B
Short-Term Investments	6.25B	9.57B	9.28B	6.05B	0	0	0	0	0	0
Accounts Receivable	4.37B	4.59B	4.69B	4.95B	4.18B	4.72B	5.14B	5.47B	6.12B	6.18B
Days Sales Outstanding	24.44	25.77	25.59	26.7	21.49	22.66	23.41	24.35	26.57	26.78
Inventory	4.72B	4.62B	4.74B	5.02B	5.5B	5.98B	6.92B	7.07B	7.02B	7.55B
Days Inventory Outstanding	52.31	51.71	50.23	52.67	56.93	58.85	59.95	60.38	62.69	66.95
Other Current Assets	8.69B	2.14B	2.05B	2.22B	2.13B	2.1B	2.37B	1.86B	2.09B	2.1B
Total Non-Current Assets+	93.35B	93.91B	94.99B	92.62B	92.71B	96.22B	95.56B	98.18B	97.66B	99.84B
Property, Plant & Equipment	19.39B	19.89B	20.6B	21.27B	20.69B	21.69B	21.2B	21.91B	22.15B	23.9B
Fixed Asset Turnover	3.37x	3.27x	3.24x	3.18x	3.43x	3.51x	3.78x	3.74x	3.79x	3.53x
Goodwill	44.35B	44.7B	45.17B	40.27B	39.9B	40.92B	39.7B	40.66B	40.3B	41.65B
Intangible Assets	24.53B	24.19B	23.9B	24.21B	23.79B	23.64B	23.68B	23.78B	22.05B	21.91B
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	5.09B	5.13B	5.31B	6.86B	8.33B	9.96B	10.98B	11.83B	13.16B	12.38B
Total Assets+	127.14B	120.41B	118.31B	115.09B	120.7B	119.31B	117.21B	120.83B	122.37B	125.23B
Asset Turnover	0.51x	0.54x	0.56x	0.59x	0.59x	0.64x	0.68x	0.68x	0.69x	0.67x
Asset Growth %	-0.02%	-0.05%	-0.02%	-0.03%	0.05%	-0.01%	-0.02%	0.03%	0.01%	0.02%
Total Current Liabilities+	30.77B	30.21B	28.24B	30.01B	32.98B	33.13B	33.08B	35.76B	33.63B	36.06B
Accounts Payable	9.32B	9.63B	10.34B	11.26B	12.07B	13.72B	14.88B	14.6B	15.36B	15.23B
Days Payables Outstanding	103.43	107.72	109.65	118.21	124.99	134.95	128.85	124.61	137.29	135.02
Short-Term Debt	11.65B	13.55B	10.42B	9.7B	11.18B	8.89B	8.64B	10.23B	7.19B	9.51B
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	6.4B	3.6B	3.97B	4.41B	5.26B	5.53B	4.88B	5.75B	5.33B	5.74B
Current Ratio	1.10x	0.88x	0.83x	0.75x	0.85x	0.70x	0.65x	0.63x	0.73x	0.70x
Quick Ratio	0.94x	0.72x	0.66x	0.58x	0.68x	0.52x	0.45x	0.44x	0.53x	0.49x
Cash Conversion Cycle	-26.68	-30.23	-33.83	-38.84	-46.57	-53.45	-45.49	-39.88	-48.02	-41.28
Total Non-Current Liabilities+	38.38B	34.42B	37.19B	37.51B	40.85B	39.52B	37.27B	38.01B	38.19B	36.89B
Long-Term Debt	18.95B	18.04B	20.86B	20.39B	23.54B	23.1B	22.85B	24.38B	25.27B	25B
Capital Lease Obligations	29M	38M	85M	0	652M	631M	595M	595M	666M	701M
Deferred Tax Liabilities	9.11B	8.13B	6.16B	6.9B	6.2B	6.15B	6.81B	6.48B	6.52B	5.77B
Other Non-Current Liabilities	10.3B	8.22B	10.08B	10.21B	10.46B	9.64B	7.02B	6.56B	5.73B	5.42B
Total Liabilities	69.15B	64.63B	65.43B	67.52B	73.82B	72.65B	70.35B	73.76B	71.81B	72.95B
Total Debt+	30.64B	31.64B	31.39B	30.1B	35.61B	32.84B	32.29B	35.42B	33.37B	35.46B
Net Debt	23.54B	26.07B	28.82B	25.86B	19.43B	22.55B	25.08B	27.18B	23.89B	25.91B
Debt / Equity	0.53x	0.57x	0.59x	0.63x	0.76x	0.70x	0.69x	0.75x	0.66x	0.68x
Debt / EBITDA	1.86x	1.91x	1.94x	3.62x	1.90x	1.58x	1.57x	1.70x	1.56x	1.52x
Net Debt / EBITDA	1.43x	1.57x	1.78x	3.11x	1.04x	1.09x	1.22x	1.30x	1.11x	1.11x
Interest Coverage	23.21x	29.60x	26.41x	10.78x	33.78x	35.83x	40.58x	23.99x	20.05x	22.55x
Total Equity+	57.98B	55.78B	52.88B	47.58B	46.88B	46.65B	46.85B	47.06B	50.56B	52.28B
Equity Growth %	-0.08%	-0.04%	-0.05%	-0.1%	-0.01%	-0%	0%	0%	0.07%	0.03%
Book Value per Share	20.38	20.35	19.91	18.74	17.85	17.94	18.45	18.95	20.45	21.30
Total Shareholders' Equity	57.34B	55.18B	52.29B	47.19B	46.52B	46.38B	46.59B	46.78B	50.29B	52.01B
Common Stock	4.01B	4.01B	4.01B	4.01B	4.01B	4.01B	4.01B	4.01B	4.01B	4.01B
Retained Earnings	87.95B	96.12B	98.64B	94.92B	100.24B	106.37B	112.43B	118.17B	123.81B	129.97B
Treasury Stock	-82.18B	-93.72B	-99.22B	-100.41B	-105.57B	-114.97B	-123.38B	-129.74B	-133.38B	-138.7B
Accumulated OCI	-15.91B	-14.63B	-14.75B	-14.94B	-16.16B	-13.74B	-12.19B	-12.22B	-11.9B	-12.14B
Minority Interest	642M	594M	590M	385M	357M	276M	265M	288M	272M	272M

Cash Flow

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Cash from Operations+	15.44B	12.75B	14.87B	15.24B	17.4B	18.37B	16.72B	16.85B	19.85B	17.82B
Operating CF Margin %	0.24%	0.2%	0.22%	0.23%	0.25%	0.24%	0.21%	0.21%	0.24%	0.21%
Operating CF Growth %	0.06%	-0.17%	0.17%	0.03%	0.14%	0.06%	-0.09%	0.01%	0.18%	-0.1%
Net Income	10.6B	15.33B	9.86B	3.97B	13.1B	14.35B	14.79B	14.74B	14.88B	16.07B
Depreciation & Amortization	3.08B	2.82B	2.83B	2.82B	3.01B	2.73B	2.81B	2.71B	2.9B	2.85B
Stock-Based Compensation	342M	366M	395M	515M	558M	540M	528M	545M	562M	476M
Deferred Taxes	-815M	-601M	-1.84B	-411M	-596M	-258M	-402M	-453M	-244M	149M
Other Non-Cash Items	586M	-4.71B	601M	7.98B	115M	631M	144M	524M	2.19B	755M
Working Capital Changes	1.64B	-443M	3.02B	368M	1.21B	371M	-1.15B	-1.22B	-436M	-2.47B
Change in Receivables	35M	-322M	-177M	-276M	634M	-342M	-694M	-307M	-766M	45M
Change in Inventory	116M	71M	-188M	-239M	-637M	-309M	-1.25B	-119M	-70M	-324M
Change in Payables	1.28B	-149M	1.39B	1.86B	1.92B	1.39B	1.43B	313M	1.81B	-542M
Cash from Investing+	-5.58B	-6.68B	-3.51B	-3.49B	3.04B	-2.83B	-4.42B	-3.5B	-3.5B	-3.82B
Capital Expenditures	-3.31B	-3.38B	-3.72B	-3.35B	-3.07B	-2.79B	-3.16B	-3.06B	-3.32B	-3.77B
CapEx % of Revenue	0.05%	0.05%	0.06%	0.05%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-564M	571M	269M	394M	30M	42M	110M	327M	-161M	-34M
Cash from Financing+	-9.21B	-8.57B	-14.38B	-9.99B	-8.37B	-21.53B	-14.88B	-12.15B	-14.86B	-14.04B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-7.44B	-7.24B	-7.31B	-7.5B	-7.79B	-8.26B	-8.77B	-9B	-9.31B	-9.87B
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	2.67B	2.47B	1.18B	3.32B	1.98B	1.64B	2B	1.27B	1.91B	-1M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	12.12B	9.37B	11.15B	11.89B	14.33B	15.58B	13.57B	13.79B	16.52B	14.04B
FCF Margin %	0.19%	0.14%	0.17%	0.18%	0.2%	0.2%	0.17%	0.17%	0.2%	0.17%
FCF Growth %	0.11%	-0.23%	0.19%	0.07%	0.2%	0.09%	-0.13%	0.02%	0.2%	-0.15%
FCF per Share	4.26	3.42	4.20	4.68	5.46	5.99	5.34	5.55	6.68	5.72
FCF Conversion (FCF/Net Income)	1.47x	0.83x	1.52x	3.91x	1.34x	1.28x	1.13x	1.15x	1.33x	1.12x
Interest Paid	569M	518M	529M	497M	434M	531M	451M	721M	878M	896M
Taxes Paid	3.73B	3.71B	2.83B	3.06B	3.55B	3.82B	3.82B	4.28B	4.36B	4.55B

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	17.36%	26.94%	17.95%	7.76%	27.58%	30.59%	31.53%	31.2%	30.48%	31.07%
Return on Invested Capital (ROIC)	11.99%	12.64%	12.26%	5.3%	16.86%	19.91%	18.93%	18.61%	18.71%	20.1%
Gross Margin	49.6%	49.83%	48.48%	48.63%	50.32%	51.25%	47.43%	47.86%	51.39%	51.16%
Net Margin	16.09%	23.56%	14.59%	5.76%	18.36%	18.79%	18.38%	17.87%	17.7%	18.95%
Debt / Equity	0.53x	0.57x	0.59x	0.63x	0.76x	0.70x	0.69x	0.75x	0.66x	0.68x
Interest Coverage	23.21x	29.60x	26.41x	10.78x	33.78x	35.83x	40.58x	23.99x	20.05x	22.55x
FCF Conversion	1.47x	0.83x	1.52x	3.91x	1.34x	1.28x	1.13x	1.15x	1.33x	1.12x
Revenue Growth	-7.7%	-0.37%	2.73%	1.27%	4.83%	7.28%	5.35%	2.27%	2.48%	0.29%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Fabric Care And Home Care Member	20.73B	-	-	22.08B	23.73B	26.01B	27.56B	28.37B	29.5B	29.62B
Fabric Care And Home Care Member Growth	-	-	-	-	7.50%	9.60%	5.93%	2.96%	3.96%	0.41%
Baby, Feminine and Family Care Member	18.5B	-	-	17.81B	18.36B	18.85B	19.74B	20.22B	20.28B	20.25B
Baby, Feminine and Family Care Member Growth	-	-	-	-	3.13%	2.65%	4.70%	2.44%	0.30%	-0.14%
Beauty	11.48B	-	-	12.9B	13.36B	14.42B	14.74B	15.01B	15.22B	14.96B
Beauty Growth	-	-	-	-	3.58%	7.92%	2.24%	1.82%	1.41%	-1.68%
Health Care Member	7.35B	-	-	8.22B	9.03B	9.96B	10.82B	11.23B	11.79B	12B
Health Care Member Growth	-	-	-	-	9.86%	10.28%	8.72%	3.71%	5.05%	1.74%
Grooming Member	6.82B	-	-	6.2B	6.07B	6.44B	6.59B	6.42B	6.65B	6.66B
Grooming Member Growth	-	-	-	-	-2.10%	6.11%	2.28%	-2.55%	3.66%	0.12%
Corporate	422M	-	-	484M	395M	441M	744M	765M	601M	-
Corporate Growth	-	-	-	-	-18.39%	11.65%	68.71%	2.82%	-21.44%	-
Fabric & Home Care	-	20.72B	21.44B	-	-	-	-	-	-	-
Fabric & Home Care Growth	-	-	3.49%	-	-	-	-	-	-	-
Baby, Feminine & Family Care	-	18.25B	18.08B	-	-	-	-	-	-	-
Baby, Feminine & Family Care Growth	-	-	-0.94%	-	-	-	-	-	-	-
Beauty	-	11.43B	12.41B	-	-	-	-	-	-	-
Beauty Growth	-	-	8.55%	-	-	-	-	-	-	-
Health Care	-	7.51B	7.86B	-	-	-	-	-	-	-
Health Care Growth	-	-	4.58%	-	-	-	-	-	-	-
Grooming	-	6.64B	6.55B	-	-	-	-	-	-	-
Grooming Growth	-	-	-1.37%	-	-	-	-	-	-	-
Corporate	-	505M	497M	-	-	-	-	-	-	-
Corporate Growth	-	-	-1.58%	-	-	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Non-US	-	-	-	39.1B	39.7B	42.4B	43.7B	43.3B	43.5B	42.7B
Non-US Growth	-	-	-	-	1.53%	6.80%	3.07%	-0.92%	0.46%	-1.84%
UNITED STATES	27B	27.3B	27.3B	28.6B	31.3B	33.7B	36.5B	38.7B	40.5B	41.6B
UNITED STATES Growth	-	1.11%	0.00%	4.76%	9.44%	7.67%	8.31%	6.03%	4.65%	2.72%

Frequently Asked Questions

Valuation & Price

The Procter & Gamble Company (PG) has a price-to-earnings (P/E) ratio of 22.2x. This is roughly in line with market averages.

Growth & Financials

The Procter & Gamble Company (PG) reported $84.93B in revenue for fiscal year 2025. This represents a 4% increase from $82.01B in 2012.

The Procter & Gamble Company (PG) grew revenue by 0.3% over the past year. Growth has been modest.

Yes, The Procter & Gamble Company (PG) is profitable, generating $16.77B in net income for fiscal year 2025 (19.0% net margin).

Dividend & Returns

Yes, The Procter & Gamble Company (PG) pays a dividend with a yield of 2.79%. This makes it attractive for income-focused investors.

The Procter & Gamble Company (PG) has a return on equity (ROE) of 31.1%. This is excellent, indicating efficient use of shareholder capital.

The Procter & Gamble Company (PG) generated $14.94B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...